Trial Profile
Evaluation of Clinical Response and Safety in HIV Positive Subjects Co-infected With Hepatitis C Treated With a Kaletra Containing HAART Regimen.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Lopinavir/ritonavir (Primary)
- Indications HIV infections
- Focus Therapeutic Use
- Sponsors Abbott Laboratories
- 02 Jan 2013 Status changed from discontinued to completed as reported by ClinicalTrials.gov.
- 20 Nov 2008 Status changed from completed to discontinued, according to clinicaltrials.gov.
- 09 Aug 2007 Status changed from recruiting to in progress.